全球医用吸入一氧化氮市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，医用吸入一氧化氮市场规模将从 2025 年的 11.4 亿美元成长至 22.8 亿美元，2026 年至 2034 年的复合年增长率为 7.97%。

受呼吸系统疾病治疗中吸入型一氧化氮需求不断增长的推动，全球医用吸入型一氧化氮市场呈现稳定成长态势。吸入型一氧化氮广泛用于治疗新生儿缺氧性呼吸衰竭和肺动脉高压。呼吸系统疾病盛行率的上升也促进了市场扩张。

关键成长要素包括管理系统的进步和加护病房对呼吸治疗的日益重视。医疗服务提供者致力于透过标靶治疗改善患者预后。人们对专业呼吸照护的认识不断提高，进一步推动了市场需求。此外，新生儿护理设施的扩建也促进了市场成长。

展望未来，携带式给药设备的技术进步预计将对市场产生正面影响。新兴市场对先进医疗基础设施的投资将创造新的机会。各公司正致力于提高生产成本效益并确保符合监管要求。随着全球呼吸照护的进步，全球医用吸入一氧化氮市场预计将稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球医用吸入一氧化氮市场：依产品类型划分

• 市场分析、洞察与预测
• 一氧化氮吸入供应系统
• 一氧化氮感测器和监测器

第五章 全球医用吸入一氧化氮市场：依给药途径划分

• 市场分析、洞察与预测
• 吸入用一氧化氮气体
• 使用氧气混合气体吸入一氧化氮

第六章 全球医用吸入一氧化氮市场：依应用领域划分

• 市场分析、洞察与预测
• 心血管疾病
• 呼吸系统疾病

第七章 全球医用吸入一氧化氮市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊所

第八章 全球医用吸入一氧化氮市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bellerophon Therapeutics
  • Praxair Technology Inc.（Linde Plc）
  • Mallinckrodt Pharmaceuticals
  • GE Healthcare
  • Mitsubishi Tanabe Pharma Corporation
  • Vero Biotech LLC
  • Messer Group
  • Air Liquide
  • Nu-Med Plus
  • Beyond Air Inc
  • Others

The Medical Inhaled Nitric Oxide Market size is expected to reach USD 2.28 Billion in 2034 from USD 1.14 Billion (2025) growing at a CAGR of 7.97% during 2026-2034.

The Global Medical Inhaled Nitric Oxide Market is witnessing steady growth driven by increasing use in treating respiratory conditions. Inhaled nitric oxide is commonly used for neonatal hypoxic respiratory failure and pulmonary hypertension. Growing prevalence of respiratory disorders is supporting market expansion.

Key growth drivers include advancements in delivery systems and increasing adoption in intensive care units. Healthcare providers are focusing on improving patient outcomes through targeted therapies. Rising awareness about specialized respiratory treatments is further boosting demand. Additionally, expanding neonatal care facilities are contributing to market growth.

Looking ahead, the market is expected to benefit from technological improvements in portable delivery devices. Emerging markets investing in advanced healthcare infrastructure will create new opportunities. Companies are focusing on cost-effective production and regulatory compliance. As respiratory care advances globally, the Global Medical Inhaled Nitric Oxide Market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Inhaled Nitric Oxide Delivery Systems
• Nitric Oxide Sensors And Monitors

By Route Of Administration

• Inhaled Nitric Oxide Gas
• Inhaled Nitric Oxide With Oxygen Mixtures

By Application

• Cardiovascular Disorders
• Respiratory Disorders

By End User

• Hospitals
• Clinics

COMPANIES PROFILED

• Bellerophon Therapeutics, Praxair Technology Inc Linde plc, Mallinckrodt Pharmaceuticals, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Vero Biotech LLC, Messer Group, Air Liquide, NuMed Plus, Beyond Air Inc, Others
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Kilo Tons)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Inhaled Nitric Oxide Delivery Systems Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 4.3. Nitric Oxide Sensors And Monitors Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Kilo Tons)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Inhaled Nitric Oxide Gas Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 5.3. Inhaled Nitric Oxide With Oxygen Mixtures Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 6.3. Respiratory Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY END USER 2022-2034 (USD MN and Kilo Tons)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
• 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 8. GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.2.1 By Product Type
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.3.1 By Product Type
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.4.1 By Product Type
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.5.1 By Product Type
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
  • 8.6.1 By Product Type
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MEDICAL INHALED NITRIC OXIDE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bellerophon Therapeutics
  • 10.2.2 Praxair Technology Inc. (Linde Plc)
  • 10.2.3 Mallinckrodt Pharmaceuticals
  • 10.2.4 GE Healthcare
  • 10.2.5 Mitsubishi Tanabe Pharma Corporation
  • 10.2.6 Vero Biotech LLC
  • 10.2.7 Messer Group
  • 10.2.8 Air Liquide
  • 10.2.9 Nu-Med Plus
  • 10.2.10 Beyond Air Inc
  • 10.2.11 Others